D. E. Shaw & Co., Inc. - ANACOR PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ANACOR PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$4,703,000
-75.3%
87,990
-47.9%
0.01%
-72.4%
Q4 2015$19,066,000
+3.8%
168,770
+8.2%
0.03%
+7.4%
Q3 2015$18,365,000
+34.8%
156,022
-11.3%
0.03%
+35.0%
Q2 2015$13,625,000
+99.0%
175,966
+48.7%
0.02%
+81.8%
Q1 2015$6,848,000
+384.0%
118,375
+169.8%
0.01%
+450.0%
Q4 2014$1,415,000
+33.7%
43,869
+1.4%
0.00%
+100.0%
Q3 2014$1,058,000
+195.5%
43,252
+114.4%
0.00%
Q2 2014$358,000
+23.0%
20,174
+38.8%
0.00%
Q1 2014$291,000
-66.5%
14,533
-72.0%
0.00%
-100.0%
Q4 2013$869,000
+62.1%
51,814
+2.6%
0.00%0.0%
Q3 2013$536,00050,4860.00%
Other shareholders
ANACOR PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 1,067,892$125,702,00041.75%
VHCP Management, LLC 1,178,474$138,718,00035.56%
Palo Alto Investors LP 2,579,154$303,592,00014.60%
Baker Brothers Advisors 4,135,412$486,779,0004.50%
APIS CAPITAL ADVISORS, LLC 23,000$2,708,0003.75%
EMORY UNIVERSITY 11,096$1,306,0003.64%
Atika Capital Management LLC 61,000$7,180,0003.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 488,912$57,550,0002.78%
Segantii Capital Management Ltd 100,000$11,134,0002.55%
NEXT CENTURY GROWTH INVESTORS LLC 428,835$50,478,0002.10%
View complete list of ANACOR PHARMACEUTICALS INC shareholders